2008The company cooperated with France Bio-Mérieux to establish Shanghai Mérieux Bioengineering Co.
2007October Holdings invested in the establishment of Shanghai Kewa Laboratory Medical Products Co.
2006Invested in the establishment of Shanghai Kewa Qi Effect Computer Technology Co.
2005Increased the shareholding of Shanghai Industrial Kewa Biotechnology Co., Ltd. and made it a wholly-owned subsidiary of Kewa.
October, completed the reform of shareholding distribution.
2004Kewa Bio was successfully listed on the stock market, with an initial public offering of 18 million RMB ordinary shares (A shares).
2001Kewa invested in the establishment of Shanghai Kewa Laboratory Systems Co., Ltd. specializing in the development and production of medical testing instruments.
1999Invested in the establishment of Shanghai Kewa Enterprise Development Co., Ltd. specializing in the agency sales of international famous brands of medical testing instruments.
Invested in the establishment of Shanghai Kehua Information Technology Co., Ltd. specializing in the development of various types of testing instrument software and information management system software for hospital testing departments and blood stations and blood banks.
1998Kewa was restructured and established Shanghai Kewa Bioengineering Co., Ltd (Kewa Bio) to develop and produce clinical immunodiagnostic reagents and clinical chemical diagnostic reagents, which represented the latest biotechnology level.
1995Shanghai Kewa Biotechnology Co., Ltd. established Shanghai Kewa Dongling Diagnostic Products Co., Ltd. as a joint venture with Toyo Boshoku Co. Ltd. to research, develop and produce clinical chemical diagnostic reagents. The liquid double-dose reagents it firstly introduced led the development direction of clinical chemical diagnostic reagents in China.
Shanghai Industrial Kewa Biotechnology Co., Ltd. and SIIC*** invested in the establishment of Shanghai Industrial Kewa Biopharmaceutical Co., Ltd. to develop and produce recombinant gene-engineered drugs.
Shanghai Industrial Kewa Biotechnology Co., Ltd. was established in 1991 as a joint venture between Kewa and Hong Kong Shanghai Industrial (Group) Co., Ltd. for the research, development and production of clinical immunodiagnostic reagents such as Hepatitis B assay kits. Ltd. to research, develop and produce clinical immunodiagnostic reagents such as Hepatitis B test kits, etc. It has developed into one of the largest and most advanced clinical immunodiagnostic reagent production bases in China.
Shanghai Kewa Biochemical Reagent Laboratory was established in 1981, producing prothrombin time determination reagents, hepatitis B blood cells and other products.